04:09 PM EST, 02/07/2025 (MT Newswires) -- Mikhail Eydelman, Senior Vice President, General Counsel & Corporate Secretary, on February 05, 2025, sold 5,000 shares in Vaxcyte ( PCVX ) for $450,369. Following the Form 4 filing with the SEC, Eydelman has control over a total of 28,222 common shares of the company, with 28,222 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/xslF345X05/wk-form4_1738962245.xml